Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic
RESEARCH TRIANGLE PARK, N.C., May 30, 2012 /CNW/ - Stiefel, a GSK company, and Welichem Biotech, Inc. (WBI:CN), have entered into an agreement...